Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|July 19, 2021
Evaluating the utility of therapeutic drug monitoring in the clinical use of small molecule kinase inhibitors: a review of the literatureAlia Fahmy, Ashley M Hopkins, Michael J Sorich, et al.
Clinical Pharmacology and Therapeutics|October 8, 2021
Leveraging Human Plasma-Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Cytochrome P450 3A4 by ModafinilA David Rodrigues, Linda S Wood, Manoli Vourvahis, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib DosingWarit Ruanglertboon, Michael J Sorich, Ashley M Hopkins, et al.
The Oncologist|April 5, 2021
Regarding the Article by Rugo et alSarah Badaoui, Andrew Rowland, Michael J Sorich, et al.
Therapeutic Advances in Medical Oncology|February 14, 2018
Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ studyArduino A Mangoni, Ganessan Kichenadasse, Andrew Rowland, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2009
Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parametersAndrew Rowland, Kathleen M Knights, Peter I Mackenzie, et al.
Breast (Edinburgh, Scotland)|June 7, 2019
Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansineAshley M Hopkins, Andrew Rowland, Jessica M Logan, et al.
Circulation. Cardiovascular Genetics|September 27, 2014
CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysisMichael J Sorich, Andrew Rowland, Ross A McKinnon, et al.
Molecules (Basel, Switzerland)|March 14, 2026
Computational and Molecular Dynamics Insights into the Antithrombotic Mechanism of Triterpenes Derived from <i>Melaleuca bracteata</i> var. Revolution Gold (Myrtaceae)Patrick Appiah-Kubi, Foluso Oluwagbemiga Osunsanmi, Andrew Rowland Opoku, et al.
The AAPS Journal|June 21, 2019
Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-inductionAsha J Kapetas, Michael J Sorich, A David Rodrigues, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Expert Opinion on Drug Metabolism & Toxicology|July 19, 2021
Evaluating the utility of therapeutic drug monitoring in the clinical use of small molecule kinase inhibitors: a review of the literatureAlia Fahmy, Ashley M Hopkins, Michael J Sorich, et al.
Clinical Pharmacology and Therapeutics|October 8, 2021
Leveraging Human Plasma-Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Cytochrome P450 3A4 by ModafinilA David Rodrigues, Linda S Wood, Manoli Vourvahis, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib DosingWarit Ruanglertboon, Michael J Sorich, Ashley M Hopkins, et al.
The Oncologist|April 5, 2021
Regarding the Article by Rugo et alSarah Badaoui, Andrew Rowland, Michael J Sorich, et al.
Therapeutic Advances in Medical Oncology|February 14, 2018
Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ studyArduino A Mangoni, Ganessan Kichenadasse, Andrew Rowland, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 29, 2009
Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parametersAndrew Rowland, Kathleen M Knights, Peter I Mackenzie, et al.
Breast (Edinburgh, Scotland)|June 7, 2019
Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansineAshley M Hopkins, Andrew Rowland, Jessica M Logan, et al.
Circulation. Cardiovascular Genetics|September 27, 2014
CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysisMichael J Sorich, Andrew Rowland, Ross A McKinnon, et al.
Molecules (Basel, Switzerland)|March 14, 2026
Computational and Molecular Dynamics Insights into the Antithrombotic Mechanism of Triterpenes Derived from <i>Melaleuca bracteata</i> var. Revolution Gold (Myrtaceae)Patrick Appiah-Kubi, Foluso Oluwagbemiga Osunsanmi, Andrew Rowland Opoku, et al.
The AAPS Journal|June 21, 2019
Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-inductionAsha J Kapetas, Michael J Sorich, A David Rodrigues, et al.
Pageof 19